Publications
- The requirements for dasatinib sensitivity in human melanoma cell lines2014 | First Faculty of Medicine
- Inhibition of mTORC1 by SU6656, the Selective Src Kinase Inhibitor, Is Not Accompanied by Activation of Akt/PKB Signalling in Melanoma Cells2013 | First Faculty of Medicine, Third Faculty of Medicine
- Different effects of the inhibition of Src activity on Akt/PKB in melanoma cells with wild BRAF and mutated BRAF V600E2013 | First Faculty of Medicine
- Src-dependent activation of the mTOR signaling in melanoma cells2012 | First Faculty of Medicine
- Involvement of c-Src activity in the mTOR-dependent oncogenicity of melanoma cellsPublication without faculty affiliation
- Activity of c-Src as a novel target for the inhibition of mTOR signaling in human diseasesPublication without faculty affiliation
- The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells2023 | First Faculty of Medicine, Second Faculty of Medicine
- Many Distinct Ways Lead to Drug Resistance in BRAF- and NRAS-Mutated Melanomas2021 | First Faculty of Medicine
- Importance of Aberrantly Activated Hedgehog/Gli Pathway in Tumour Progression2020 | First Faculty of Medicine
- Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells2018 | First Faculty of Medicine
Loading network view...